138 related articles for article (PubMed ID: 38394744)
1. Ventilatory capacity in CLAD is driven by dysfunctional airway structure.
Kerckhof P; Ambrocio GPL; Beeckmans H; Kaes J; Geudens V; Bos S; Willems L; Vermaut A; Vermant M; Goos T; De Fays C; Aversa L; Mohamady Y; Vanstapel A; Orlitová M; Van Slambrouck J; Jin X; Varghese V; Josipovic I; Boone MN; Dupont LJ; Weynand B; Dubbeldam A; Van Raemdonck DE; Ceulemans LJ; Gayan-Ramirez G; De Sadeleer LJ; McDonough JE; Vanaudenaerde BM; Vos R
EBioMedicine; 2024 Mar; 101():105030. PubMed ID: 38394744
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
3. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
5. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.
Weigt SS; Kim GJ; Jones HD; Ramsey AL; Amubieya O; Abtin F; Pourzand L; Lee J; Shino MY; DerHovanessian A; Stripp B; Noble PW; Sayah DM; Saggar R; Britton I; Lynch JP; Belperio JA; Goldin J
Transplantation; 2022 Jun; 106(6):1253-1261. PubMed ID: 34534193
[TBL] [Abstract][Full Text] [Related]
7. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
[TBL] [Abstract][Full Text] [Related]
9. Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
Kubo Y; Sugimoto S; Shiotani T; Matsubara K; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Toyooka S
Clin Transplant; 2023 Nov; 37(11):e15077. PubMed ID: 37461238
[TBL] [Abstract][Full Text] [Related]
10. Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure.
Verleden SE; Vasilescu DM; McDonough JE; Ruttens D; Vos R; Vandermeulen E; Bellon H; Geenens R; Verbeken EK; Verschakelen J; Van Raemdonck DE; Wuyts WA; Sokolow Y; Knoop C; Cooper JD; Hogg JC; Verleden GM; Vanaudenaerde BM
Eur Respir J; 2015 Nov; 46(5):1430-9. PubMed ID: 26113688
[TBL] [Abstract][Full Text] [Related]
11. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
12. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
13. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
[TBL] [Abstract][Full Text] [Related]
14. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
Front Immunol; 2021; 12():661761. PubMed ID: 34122421
[TBL] [Abstract][Full Text] [Related]
15. Transition from BOS to RAS impairs prognosis after lung transplantation-CLAD subtype analysis by CT volumetry.
Peräkylä L; Nykänen A; Piilonen A; Kesävuori R; Halme M; Raivio P
PLoS One; 2022; 17(10):e0275563. PubMed ID: 36223371
[TBL] [Abstract][Full Text] [Related]
16. Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
Sato M
Ann Transl Med; 2020 Mar; 8(6):418. PubMed ID: 32355862
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
[TBL] [Abstract][Full Text] [Related]
18. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
19. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
